Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

002118

CNE000001R43

Jilin Zixin Pharmaceutical Industrial Co.,Ltd Announces Board Elections

May 22, 2019 at 11:32 am

Jilin Zixin Pharmaceutical Industrial Co.,Ltd at its Annual General Meeting of 2018 on 21 May 2019, elected Guo Chunlin, Feng Youshun and Luan Fumei as non-independent directors. The company also elected Ren Yueying, Yan Zhonghai and Cheng Yan as independent directors.

Latest news about Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange A Share Index	23-08-04	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Composite Index	23-08-04	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Approves Board Appointments	23-05-30	CI
Jilin Zixin Pharma CFO Resigns; Successor Named; Shares Slump 5%	23-05-10	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt	23-05-07	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Jilin Zixin Pharma Chairman Resigns	23-04-19	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Appoints Chen Fu as Non-Independent Directors	23-01-16	CI
Jilin Zixin Pharma Elects Chairman	23-01-16	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt	22-06-28	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Announces Board Changes	22-05-24	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-23	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(XSEC:002118) dropped from S&P Global BMI Index	20-12-21	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Component A Share Index	20-12-14	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Component Index	20-12-11	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Jilin Hengde Investment Information Consulting Co., Ltd. agreed to acquire Jilin Zixin Dunhua Medicine & Herbs Co., Ltd. from Jilin Zixin Pharmaceutical Industrial Co.,Ltd. for CNY 1 million.	20-08-27	CI

Chart Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Duration

Period

Chart Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

More charts

Company Profile

JILIN ZIXIN PHARMACEUTICAL INDUSTRIAL CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of traditional Chinese patent drugs and ginseng products. The Company operates its businesses through three segments. The Traditional Chinese Patent Drugs segment mainly provides traditional Chinese patent drugs for the treatment of rheumatoid immunity, ear-nose-throat (ENT), urinary system cardiovascular, hepatobiliary and digestive diseases. The Ginseng Products segment is engaged in the provision of deep processing products and rough-wrought products, including white ginseng products, red ginseng products, drinks and candied fruits. The Gene Sequencing segment is engaged in the research and development, manufacture and distribution of gene sequencing machines and supporting reagents.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.25B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.87B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.37B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.89B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.58B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.54B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B

Alternative Medicine